Next Article in Journal
Facile Synthesis of Heterocycles via 2-Picolinium Bromide and Antimicrobial Activities of the Products
Next Article in Special Issue
Prodrugs in Cardiovascular Therapy
Previous Article in Journal
The Influence of Hofmeister Series Ions on Hyaluronan Swelling and Viscosity
Previous Article in Special Issue
Cytoprotective Efficacy of Amifostine Against Radiation- Induced Rectal Toxicity: Objective and Subjective Grading Scales for Radiomucositis
Molecules 2008, 13(5), 1035-1065; doi:10.3390/molecules13051035
Review

Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach

1,* , 2, 2, 1, 2 and 2
Received: 1 February 2008; in revised form: 1 April 2008 / Accepted: 30 April 2007 / Published: 1 May 2008
(This article belongs to the collection Prodrugs)
Download PDF [225 KB, uploaded 18 June 2014]
Abstract: This review describes specific strategies for targeting to the central nervoussystem (CNS). Systemically administered drugs can reach the brain by crossing one of twophysiological barriers resistant to free diffusion of most molecules from blood to CNS: theendothelial blood-brain barrier or the epithelial blood-cerebrospinal fluid barrier. Thesetissues constitute both transport and enzymatic barriers. The most common strategy fordesigning effective prodrugs relies on the increase of parent drug lipophilicity. However,increasing lipophilicity without a concomitant increase in rate and selectivity of prodrugbioconversion in the brain will result in failure. In these regards, consideration of theenzymes present in brain tissue and in the barriers is essential for a successful approach.Nasal administration of lipophilic prodrugs can be a promising alternative non-invasiveroute to improve brain targeting of the parent drugs due to fast absorption and rapid onsetof drug action. The carrier-mediated absorption of drugs and prodrugs across epithelial andendothelial barriers is emerging as another novel trend in biotherapeutics. Several specifictransporters have been identified in boundary tissues between blood and CNScompartments. Some of them are involved in the active supply of nutrients and have been used to explore prodrug approaches with improved brain delivery. The feasibility of CNSuptake of appropriately designed prodrugs via these transporters is described in detail.
Keywords: Brain delivery; nasal administration; prodrugs; SVCT2; carrier-mediated transport Brain delivery; nasal administration; prodrugs; SVCT2; carrier-mediated transport
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Pavan, B.; Dalpiaz, A.; Ciliberti, N.; Biondi, C.; Manfredini, S.; Vertuani, S. Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach. Molecules 2008, 13, 1035-1065.

AMA Style

Pavan B, Dalpiaz A, Ciliberti N, Biondi C, Manfredini S, Vertuani S. Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach. Molecules. 2008; 13(5):1035-1065.

Chicago/Turabian Style

Pavan, Barbara; Dalpiaz, Alessandro; Ciliberti, Nunzia; Biondi, Carla; Manfredini, Stefano; Vertuani, Silvia. 2008. "Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach." Molecules 13, no. 5: 1035-1065.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert